Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 15, 2022 | Debt Financing | $15M | 1 | Silicon Valley Bank | — | Detail |
Oct 22, 2021 | Series B | $52M | 8 | Accelmed , H.I.G. BioHealth Partners | — | Detail |
Dec 1, 2020 | Debt Financing | $30M | 1 | K2 HealthVentures | — | Detail |
Sep 11, 2020 | Funding Round | $500M | 1 | Boehringer Ingelheim | — | Detail |
Dec 11, 2018 | Funding Round | $302M | 1 | — | — | Detail |
Oct 4, 2018 | Series A | $19M | 2 | Sanofi Ventures | — | Detail |
Apr 5, 2017 | Convertable Note | $3.70M | 1 | Magellan Health Services | — | Detail |
Apr 19, 2016 | Convertable Note | $0.95M | — | — | — | Detail |
Aug 6, 2015 | Convertable Note | $1.83M | 1 | — | — | Detail |
Oct 1, 2014 | Convertable Note | $1.70M | — | — | — | Detail |
Apr 15, 2012 | Seed | $200K | 3 | — | — | Detail |